Mary Cross
Impact in
-
- Intensive Care Unit Cognitive Disorders
- Endocrine and Autonomic Systems top 10%
Papers in
-
- Intensive Care Unit Cognitive Disorders 3
- Co-authors
- Deborah AshbyAnthony GordonGavin D. PerkinsShalini SanthakumaranDaniel F. McAuleyAlexina J. MasonR. OrmeFarah Al-Beidh
- Journals
- Journal of Hypertension (2 papers)Intensive Care Medicine (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)BMJ Open (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesGreece
In The Last Decade
Mary Cross
14 papers receiving 639 citations
Peers
Comparison fields: 5 of 88
- Critical Care and Intensive Care Medicine 82
- Endocrine and Autonomic Systems 68
- Developmental Neuroscience 41
- Emergency Medicine 71
- Health, Toxicology and Mutagenesis 100
Countries citing papers authored by Mary Cross
This map shows the geographic impact of Mary Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Cross more than expected).
Fields of papers citing papers by Mary Cross
This network shows the impact of papers produced by Mary Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Cross. The network helps show where Mary Cross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 17 | |
| 2 | 2020 | 16 | |
| 3 | 2019 | 42 | |
| 4 | 2018 | 5 | |
| 5 | 2018 | 53 | |
| 6 | A Randomised, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy Of Oral Azithromycin (500 Mg Od) As A Supplement To Standard Care For Adult Patients With Acute Exacerbations Of Asthma (the Azalea Trial) | 2016 | 1 |
| 7 | 2016 | 8 | |
| 8 | 2016 | 225 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 57 | |
| 11 | 2016 | 0 | |
| 12 | 2008 | 81 | |
| 13 | Acute sinusitis: which factors do FPs believe are most diagnostic and best predict antibiotic efficacy? | 2006 | 3 |
| 14 | 2006 | 30 | |
| 15 | 2005 | 121 |
About Mary Cross
Mary Cross is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology, Developmental Neuroscience, Otorhinolaryngology and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 660 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (3 papers), Intensive Care Unit Cognitive Disorders (3 papers), Sepsis Diagnosis and Treatment (3 papers), Anesthesia and Neurotoxicity Research (2 papers), Enhanced Recovery After Surgery (2 papers), Heart Failure Treatment and Management (2 papers), Hemodynamic Monitoring and Therapy (2 papers) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (82 citations), Endocrine and Autonomic Systems (68 citations), Developmental Neuroscience (41 citations), Emergency Medicine (71 citations) and Health, Toxicology and Mutagenesis (100 citations). Mary Cross has collaborated with scholars based in United Kingdom, United States and Greece. Frequent co-authors include Deborah Ashby, Anthony Gordon, Gavin D. Perkins, Shalini Santhakumaran, Daniel F. McAuley, Alexina J. Mason, R. Orme, Farah Al-Beidh, Mervyn Singer and Lewis E. Braverman. Their work appears in journals such as Journal of Hypertension, Intensive Care Medicine, The Journal of Clinical Endocrinology & Metabolism, BMJ Open and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.